antipyrine has been researched along with papaverine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (57.14) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, G; Ermondi, G | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Steen, JB; Stray-Pedersen, S | 1 |
| DeYoung, NJ; Duncan, HJ; Faris, IB | 1 |
| Cheong, DK; Gangarosa, LP | 1 |
| Johansson, B | 1 |
| Arnold, W | 1 |
| Budewski, O; Dshoneydi, M; Ivanova, J; Michailova, S | 1 |
| Kessler, H | 1 |
| Iven, A | 1 |
| Hansen, P | 1 |
| Maier-Lenz, H; Ringwelski, L; Windorfer, A | 1 |
| Iadecola, C; Xu, X | 1 |
| GOECHT, R | 1 |
| KRISCHEK, J | 1 |
21 other study(ies) available for antipyrine and papaverine
| Article | Year |
|---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The capillary permeability of the rete mirabile of the eel, Anguilla vulgaris L.
Topics: Anguilla; Animals; Antipyrine; Capillary Permeability; Dextrans; Ethanol; Models, Biological; Osmosis; Papaverine; Perfusion; Potassium; Sodium; Sucrose; Time Factors; Urea | 1975 |
The effectiveness of local injections of vasodilating agents to produce vasodilation in subcutaneous tissue in rabbits.
Topics: Alprostadil; Animals; Antipyrine; Dose-Response Relationship, Drug; Histamine; Injections, Subcutaneous; Iodine Radioisotopes; Methods; Microcirculation; Nitroprusside; Papaverine; Prostaglandins E; Rabbits; Regional Blood Flow; Vasodilation; Vasodilator Agents; Verapamil; Xenon Radioisotopes | 1985 |
The effects of adrenergic drugs and blockers upon the efficiency of isotope clearance from the subcutaneous tissues of the cat.
Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Antipyrine; Capillary Resistance; Cats; Epinephrine; Injections, Subcutaneous; Iodine Isotopes; Isoproterenol; Papaverine; Phenoxybenzamine; Phosphates; Phosphorus Isotopes; Propranolol; Sympatholytics; Sympathomimetics | 1969 |
Blood-brain barrier dysfunction in acute arterial hypertension after papaverine-induced vasodilatation.
Topics: Albumins; Animals; Antipyrine; Azo Compounds; Blood-Brain Barrier; Brain; Capillary Permeability; Cats; Cerebrovascular Circulation; Coloring Agents; Hypertension; Iodine Radioisotopes; Metaraminol; Microscopy, Fluorescence; Papaverine; Sulfonic Acids | 1974 |
[GC/MS demonstration of opium alkaloids in opium preparations (in connection with an on-line linked small computer)].
Topics: Antipyrine; Chromatography, Gas; Codeine; Computers; Morphine; Noscapine; Opium; Papaverine | 1974 |
[Quantitative analysis of drugs using thin-layer chromatography. 1. Analysis of phenazone and of papaverine hydrochloride in drug mixtures].
Topics: Antipyrine; Chromatography, Thin Layer; Drug Combinations; Papaverine; Photometry | 1972 |
[Pediatric Asthma-Bisolvon suppositories in the treatment of asthmatic bronchitis and bronchial asthma in childhood].
Topics: Adolescent; Antipyrine; Asthma; Barbiturates; Benzyl Compounds; Bronchitis; Child; Child, Preschool; Drug Combinations; Ephedrine; Expectorants; Humans; Infant; Papaverine; Suppositories; Theophylline | 1972 |
[On drug therapy of emphysema and related diseases in more advanced age].
Topics: Aged; Antipyrine; Asthma; Atropa belladonna; Bronchitis; Bronchodilator Agents; Humans; Papaverine; Phytotherapy; Plants, Medicinal; Plants, Toxic; Pulmonary Emphysema; Theophylline | 1967 |
[Factory physician and bronchitis].
Topics: Antipyrine; Asthma; Atropa belladonna; Bronchitis; Humans; Occupational Medicine; Papaverine; Phytotherapy; Plant Extracts; Plants, Medicinal; Plants, Toxic; Pulmonary Emphysema; Theophylline | 1969 |
[A comparative pharmacokinetic study for tablet and suppository formulations of a combination product of caffeine, ethaverine, propyphenazone, paracetamol and phenobarbital (author's transl)].
Topics: Acetaminophen; Adult; Analgesics; Antipyrine; Caffeine; Drug Combinations; Humans; Kinetics; Male; Papaverine; Phenobarbital; Rectum; Suppositories; Tablets | 1981 |
Nitro-L-arginine attenuates hypercapnic cerebrovasodilation without affecting cerebral metabolism.
Topics: Animals; Antipyrine; Arginine; Autoradiography; Brain; Carbon Dioxide; Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Deoxyglucose; Glucose; Male; Nitroarginine; Organ Specificity; Oxygen; Papaverine; Partial Pressure; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasodilation | 1994 |
[Experiences with Makara, a successful antiasthmatic power].
Topics: Anti-Asthmatic Agents; Antipyrine; Asthma; Ephedrine; Papaverine; Phenacetin; Theophylline | 1962 |
[Migraine therapy with migraine kranit].
Topics: Acetaminophen; Antipyrine; Caffeine; Drug Combinations; Humans; Migraine Disorders; Muscle Relaxants, Central; Papaverine; Phenobarbital | 1951 |